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Abstract
Background
Few studies have evaluated the association between quality of life (QoL) and functional
activity limitations (FAL) of leprosy patients as determined by the Screening of Activity Limi-
tation and Safety Awareness scale (SALSA).
Aim
To identify the association between FALs and the QoL of patients during and post leprosy
treatment.
Materials and Methods
Cross-sectional survey of 104 patients with leprosy followed in specialist reference centres
in Sergipe, Brazil, between June and October 2014. QoL was evaluated using the World
Health Organization-QoL-BREF (WHOQoL-BREF) questionnaire. The SALSA scale was
used to measure FALs.
Results
Low SALSA scores were present in 76% of patients. QoL scores were lower for the physical
and environmental domains, with median (interquartile range (IQR)) scores of 53.6 (32.1–
67.9) and 53.1 (46.9–64.8), respectively. There was a statistical association between
increasing SALSA scores and lower QoL as measured by the WHOQoL-BREF.
Conclusion
Functional limitations are associated with lower QoL in leprosy patients, especially in the
physical and environmental WHOQoL-BREF domains.
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Author Summary
Leprosy is still a neglected public health problem. Leprosy causes disability and functional
limitations (FALs) if not treated early. We describe the functional activity and quality of
life (QoL) of adults with leprosy attending two reference centres in Sergipe, Brazil. Patients
with leprosy had low QoL, which was associated to the degree of FALs. Despite increased
access to diagnosis and modern multidrug leprosy therapy, leprosy is still strongly associ-
ated with FALs and low QoL. We stress here the importance of public health efforts to
diagnose the disease early and to provide supportive systems for patients receiving treat-
ment in endemic areas.
Introduction
Leprosy is still a neglected public health problem with at least 200,000 new cases diagnosed
annually worldwide. The highest prevalence occurs in low and middle income countries such
as India, Brazil, Myanmar, Madagascar, Nepal, and Mozambique [1]. This chronic and insidi-
ous infection affects and impairs the skin and peripheral nerves and results in significant physi-
cal disability. This chronic and insidious infection affects and impairs the skin and peripheral
nerves and results in significant physical disability. The clinical and pathological presentation
of leprosy is determined by the immunological response toMycobacterium leprae and the
capacity of the host to develop an effective cell mediated immunity. In addition, leprosy-spe-
cific reactions are also a major cause of disability [2,3]. These reactions are called type 1 and 2,
with type 1 essentially being a reversal reaction or ‘upgrading’ of the cell mediated immunity to
M. leprae antibodies. These reactions are characterised by a marked increase in delayed type
hypersensitivity and type 1 helper T lymphocyte cytokines. Type 2 reactions in turn are consid-
ered the result of immune complexes attracting granulocytes and complement activation with
the selective activation of cytokines.
An estimated three million people exhibit leprosy-related impairments worldwide [4], gen-
erating severe social stigma and isolation, relationship and psychological problems and
decreased ability to work [4,5].
The prevalence of disabilities due to leprosy varies among countries. Brazil has increased its
detection of new cases with physical disability at diagnosis. In 2001, there was a 17.8% propor-
tion of grade 1 physical disability and 6% of grade 2. In 2008, the proportion of grade 1 was
20.7% and grade 2 was 7.7% [6].
Functional activity limitations (FALs) associated with leprosy are well described. The main
risk factors to develop FALs are the presence of leprosy reactions, presence of affected nerves,
multibacillary leprosy and delay in diagnosis and/or treatment [7]. However, little is known
about the interaction between these FALs and the quality of life (QoL). QoL is a broad concept
including physical and psychological health, personal independence, social relationships, per-
sonal beliefs and the interaction of these factors with the environment. The term QoL incorpo-
rates the multidimensional nature and perception of overall quality of life but often is quoted
as the impact of an illness or injury on the quality of life [8].
Currently, the main focus of rehabilitation centres is to prevent and treat physical
impairment and to improve the QoL of patients. Therefore it is essential to assess how func-
tional limitations affect the QoL of these patients to inform the development of interventions.
This study aimed to describe the relationship of FALs and the QoL of patients with a diag-
nosis of leprosy in an endemic area of Brazil.
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Materials and Methods
Study design and patients
This was a cross-sectional survey to describe the FALs and QoL of patients attending two lep-
rosy reference centres in Sergipe State, Northeast Brazil. Eligible criteria for inclusion in this
study were patients>15 years old with diagnosis of leprosy and in MDT treatment or in treat-
ment post-discharge for leprosy reactions. Patients with diabetes, excess alcohol consumption,
known to be infected with the Human Immunodeficiency Virus, or with mental or physical
conditions interfering with the assessment were excluded. All consecutive patients attending
(a) the University Hospital Clinic and (b) the Leprosy and Tuberculosis Reference Centre, in
Aracaju, Sergipe State, from June to October 2014 were enrolled.
Questionnaires and procedures
After obtaining written informed consent to participate, participants were interviewed using a
structured questionnaire that included demographic and clinical information (leprosy classifi-
cation, leprosy reactions and disability grade) and an evaluation of their FALs and QoL. In
addition, the clinical records of the patients and the database from the Sistema de Informação
de Agravos de Notificação (SINAN) were reviewed to confirm the diagnosis and the presence of
leprosy reactions. The SINAN is a national database containing information for all leprosy
patients in Brazil.
Patients were classified using the World Health Organisation (WHO) leprosy classification
as having paucibacillary (PB) (5 skin lesions and/or only one affected nerve trunk) or multi-
bacillary (MB) leprosy (>5 skin lesions and/or>1 affected nerve trunk). Leprosy reactions
were defined as episodes characterized by acute inflammation of skin lesions or nerves (type 1)
and/or the appearance of inflamed cutaneous nodules with/without neuritis (type 2) [2]. The
WHO disability classification was used. In this classification, grade 0 indicates no disability;
grade 1 loss of sensibility in the eyes, hands and/or feet without visible deformity and grade 2
the loss of sensitivity and visible deformities [9].
QoL was assessed using the Portuguese version of the WHO-QoL-BREF (WHOQoL-BREF)
questionnaire [10] (S1 and S2 Texts). The WHOQol-BREF is an international cross-culturally
comparable QoL assessment instrument. This instrument is subdivided into physical, psycho-
logical, social relationships and environmental domains and each item is rated on a scale from
0 to 5, with higher scores indicating better QoL [8,11].
Functional Activity Limitations were measured using the Portuguese version of the Screen-
ing of Activity Limitation and Safety Awareness (SALSA) scale (S1 and S2 Texts). The scale
measures activity limitations and risk awareness in patients who have or have had a disease
with peripheral neuropathy, as in leprosy. The scale includes assessment of the eyes, hands
(skills and labour), feet (mobility) and self-care. SALSA scores range from 10 to 80, with 10–24
allocated to patients without significant limitations; 25–39 for mild limitations and 40–49; 50–
59 and 60–80 for moderate, severe and very severe limitations, respectively. The risk awareness
score ranges from 0 to 11, with higher scores indicating greater awareness of the risks involved
in daily life activities [7,12].
All questionnaires were completed by the interviewers in a quiet private place. The two
interviewers were trained members of the team. We chose to interview the participants because
patients with leprosy are often poor and have low educational level. When a respondent did
not understand the meaning of a question, the interviewer re-read the question and did not
explain the sentence with other words. The interviewers were not involved in the treatment of
patients.
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Data analysis
Categorical variables were described using frequencies and percentages. The WHO analysis
syntax for SPSS was used to calculate the four WHOQoL-BREF domain scores. Scores were
standardised to a 4–20 scale, and domain scores were converted to a 0–100 scale as per the
WHOQoL guidelines [11]. Pearson’s Chi-square or Fisher Exact Tests were used to compare
the categorical variables association with the FALs. FALs were dichotomized as present (when
there any limitation) or absent (without limitation). DG 1 and DG 2 were considered as disabil-
ity for statistical analysis. The normal distribution of the scores was verified using the Kolmo-
gorov-Smirnov test and most WHOQoL-BREF and SALSA scores had skewed distributions.
We therefore used nonparametric tests to verify the significance of the distributions between
the study variables. Kruskal-Wallis’s test was used to assess differences between measurements
of the WHOQoL-BREF domains by the SALSA categories. When Kruskal-Wallis’s test was sig-
nificant, we performed multiple comparisons using the Dunn's test (post-hoc test) to determi-
nate differences between the groups. Spearman’s Rho correlations were used to describe the
relationship between SALSA and WHOQoL-BREF domain scores. P values<5% were consid-
ered statistically significant.
Ethics
The study was approved by the Human Research Ethics Committee of Federal University of
Sergipe (CAAE: 31078114.3.0000.5546). All investigation has been conducted according to the
Declaration of Helsinki. Informed consent written was obtained from the participants. Parents
or guardians provided written informed consent before enrolling their children in the study.
Results
One hundred and six patients were selected and invited to participate (S1 Table). Two patients
who did not understand the WHOQoL-BREF questionnaire were excluded. Of the 104 patients
included, 56 (53.8%) were male; their median (IQR) age was 48.0 (37.2–58.0) years old and the
median (IQR) schooling was 5.0 (3–10) years. Twenty (19.3%) participants were receiving mul-
tidrug therapy (MDT) for leprosy at the time of the interview and 84 (80.7%) were receiving
post-discharge treatment for leprosy reactions. There was no significant difference between the
mean ages of patients receiving MDT or post-discharge treatment for leprosy reactions.
Eighty-six (82.7%) participants had MB and 18 (17.3%) PB leprosy at the time of diagnosis.
Twenty (19.2%) patients had leprosy-related deformities (Grade 2) (Table 1).
The median (interquartile range (IQR) SALSA score was 31.0 (25.0–41.5) points, with 25
(24%) patients having no significant FALs, 52 (50%) mild, 9 (8.7%) moderate, 6 (5.8%) severe
and 12 (11.5) very severe FALs. There was an association between the presence of disabilities
and FALs (p = 0.001). The median (IQR) SALSA score was higher in patients with MB leprosy
than PB leprosy [33 (25.8–44.3) versus 25 (22.0–31.5), p = 0.02]. There was no difference in the
SALSA score by sex (p = 0.10) or leprosy reaction (p = 0.20).
The median (IQR) scores for the WHOQoL-BREF domains were: 53.6 (32.1–67.9) for phys-
ical, 62.5 (50.0–75.0) for psychological, 70.8 (58.3–75.0) for social and 53.1 (46.9–64.8) for the
environment domains (Table 1). Table 2 shows the WHOQoL-BREF scores by SALSA catego-
ries. There was a significant difference among the distribution of the SALSA categories into
physical (χ2 = 45.6; p<0.001) and environmental (χ2 = 24.9; p<0.001) domains. Pairwise com-
parisons between SALSA categories were made using the Dunn’s test. Patients with moderate
(0.001), severe (0.008) and very severe (<0.001) limitations had lower physical domain scores.
Patients with severe (0.004) and very severe (0.001) limitations had lower environmental
domain scores (Table 3).
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Increasing SALSA scores were associated with decreasing WHOQoL-BREF scores for the
physical (r = -0.68; p<0.001), psychological (r = -0.28; p = 0.003), social (r = -0.21; p = 0.03)
and environmental (r = -0.47; p<0.001) scores.
Discussion
This study describes that patients with leprosy have FALs and that their presence, as assessed
by SALSA, is associated with low QoL.
In Brazil, treatment and post-discharge follow-up of cases is routinely performed in primary
health care centres and only cases with complications are referred to the centres of reference.
Recent studies from Brazil of leprosy patients attending primary health care settings [7,13]
have reported a FALs prevalence between 24% and 58% of cases and thus the higher prevalence
observed is likely due to our participants being selected from reference centres.
Patients with leprosy had lower physical and environmental domain outcomes, which is in
agreement with other Brazilian studies evaluating the QoL of people with leprosy sequelae
[11,14]. In Bangladesh, patients undertaking leprosy treatment had lower scores in the psycho-
logical and physical domains but not in the environmental domain [15] and in India the lower
values were reported in the social and environmental domains [16]. The differences between
out study and the Asian reports therefore can be explained by the epidemiological context such
Table 1. Demographic characteristics of study participants.
Variables N = 104
Sex, male, N (%) 56 (53.8%)
Age, median (IQR*) in years 48.0 (37.2–58.0)
Schooling, median (IQR*) 5.0 (3–10)
WHO leprosy classiﬁcation, N (%)
PB leprosy 86 (82.7%)
MB leprosy 18 (17.3%)
Leprosy reactions, N (%) 84 (80.7%)
WHO disability degree, N (%)
DG0 29 (27.9%)
DG1 55 (52.9%)
DG2 20 (19.2%)
SALSA scale
Functional limitation, N (%)
Without limitation 25 (24.0%)
Mild 52 (50.0%)
Moderate 9 (8.7%)
Severe 6 (5.8%)
Very severe 12 (11.5%)
WHOQoL-BREF domains, median (IQR*)
Physical 53.6 (32.1–67.9)
Psychological 62.5 (50.0–75.0)
Social 70.8 (58.3–75.0)
Environmental 53.1 (46.9–64.8)
*Interquartile range (IQR). Paucibacillary leprosy (PB). Multibacillary leprosy (MB). Disability Grade (DG).
Screening of Activity Limitation and Safety Awareness scale (SALSA). World Health Organization-
QoL-BREF (WHOQoL-BREF).
doi:10.1371/journal.pntd.0003900.t001
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as the characteristics of patients being enrolled in the studies and differences in the cultural
and socioeconomic context, including the availability of long term rehabilitation and support
programs.
Increased FAL was associated with decreased QoL in the four domains, with greater
impairment in the physical and environmental domains. Deformities have multiple impacts on
leprosy patients because they cause both functional limitations and a decreased perception of
physical health. This is consistent with a study in India observing that physical domain scores
were lower in deformed than in non-deformed patients [15].
The QoL scores in the environmental domain were associated with the presence of FALs
with a strong inverse association between the prevalence of leprosy and income, education and
social inequity [17]. Patients reported lower scores for ‘financial resources’, ‘information avail-
able’, ‘leisure activities’ and ‘satisfaction with transport’, which is consistent the socioeconomic
level of most leprosy cases. Furthermore, the low scores in the environmental domain suggest
difficulties in accessing healthcare services, despite diagnostics, care and treatment being avail-
able free of charge.
The psychological and social domains were inversely associated with FALs, as reported by
others [4,5,15,18], although the Spearman Rho test showed a weak correlation between the
FALs and these domains. Perhaps, the higher scores in the psychological and social domains
than the physical and environment domains were due to the availability of supportive social
networks and psychology services enhancing the capacity of patients to cope with the disease
[11]. It is also important to note that we only included patients receiving treatment and those
who had leprosy reactions. It would be important to document the FALs and QoL of patients
who received leprosy treatment and have not experience leprosy reactions, as this group may
have a very different QoL than the patients reported here.
The low QoL of patients with leprosy and leprosy reactions is associated with the presence
of FALs, especially in the physical and environmental domains. Despite the increase in access
Table 2. WHOQoL-BREF domain scores stratified by functional limitations.
Functional limitation N (%) WHOQoL-BREF domains Median (IQR*)
Physical Psychological Social Environmental
Without limitation 25 (24.0) 71.4 (60.7–80.4) 70.8 (60.4–77.1) 75.0 (66.7–75.1) 62.5 (53.1–71.9)
Mild 52 (50.0) 56.6 (35.7–66.9) 62.5 (50.0–75.0) 75.0 (58.3–81.3) 53.1 (50.0–65.8)
Moderate 9 (8.7) 32.1 (30.4–46.4) 58.3 (50.0–75.0) 58.3 (45.8–79.2) 46.9 (43.8–59.4)
Severe 6 (5.8) 35.7 (25.0–51.8) 49.2 (29.2–69.8) 45.2 (12.5–87.5) 39.1 (35.2–45.3)
Very severe 12 (11.5) 25.0 54.2 58.3 45.3
p-value p<0.001a p = 0.20a p = 0.34a p<0.001a
aKruskal-Wallis’s test.
* Interquartile range (IQR).
doi:10.1371/journal.pntd.0003900.t002
Table 3. Pairwise comparison of the SALSA categories by the physical and environmental domains.
Pairwise comparison Physical domain p-value Environmental domain p-value
Without and mild 0.018 0.75
Without and moderate 0.001 0.25
Without and severe 0.008 0.004
Without and very severe <0.001 0.001
doi:10.1371/journal.pntd.0003900.t003
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to diagnosis and appropriate treatment using MDT in recent decades, patients with significant
activity limitations may face reduced QoL. Fortunately, QoL and FALs can be improved by
early treatment and rehabilitation interventions and functional limitations should be diagnosed
early and monitored to assess the impact of treatment and rehabilitation.
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